West Pharmaceutical Services | WST - Umsatzerlöse

Aktienkurs
293.58
Täglich Wechseln
-8.62 -2.85%
Monatlich
19.76%
Jährlich
35.84%
Q2 Prognose
299.61




Der Umsatz Veränderung Datum
Align Technology USD 1.05B 54.3M 2025-12
Avanos Medical USD 180.9M 3.1M 2025-12
Baxter International USD 2.97B 130M 2025-12
Becton, Dickinson and Co. USD 5.3B 600M 2025-12
Cerus USD 50.81M 4.79M 2024-12
Charles River Laboratories USD 994.2M 5.8M 2025-12
Cooper Companies USD 1.02B 41.1M 2025-12
Dentsply International USD 961M 57M 2025-12
Haemonetics USD 338.97M 11.97M 2025-12
ICU Medical USD 540.7M 3.7M 2025-12
Insulet USD 783.8M 77.5M 2025-12
Integra LifeSciences USD 434.9M 32.84M 2025-12
IQVIA Holdings USD 4.36B 260M 2025-12
J&J USD 24.1B 500M 2026-03
Medtronic USD 9B 39M 2026-01
Merit Medical Systems USD 393.9M 9.7M 2025-12
Neogen USD 211.2M 13.49M 2025-12
OraSure Technologies USD 26.76M 322K 2025-12
Quidel USD 724M 24M 2025-12
Repligen USD 197.91M 8.91M 2025-12
Rockwell Medical USD 25.83M 3.15M 2024-06
Solventum Corp USD 1.99B 110M 2025-12
STAAR Surgical USD 239.4M 144.7M 2025-12
Terumo JPY 296.63B 21.66B 2025-12
Utah Medical Products USD 9.04M 955K 2025-12
West Pharmaceutical Services USD 844.9M 39.9M 2026-03